Celyad to Participate in Upcoming June 2019 Conferences

On May 29, 2019 Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, reported that management plans to attend the following events in June 2019 (Press release, Celyad, MAY 29, 2019, View Source [SID1234536651]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference details:

BIO International Convention
Date: June 3 – 6, 2019
Location: Philadelphia, PA

William Blair 39th Annual Growth Stock Conference
Date: Wednesday, June 5, 2019
Presentation time: 8:40 – 9:10 a.m. CDT
Location: Chicago, IL

HealthTech Investor Days, France Biotech
Date: June 24 – 25, 2019
Location: Paris, France